VBP

China Medical System （867.HK）2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs

Retrieved on: 
Thursday, March 28, 2024
Sclerotherapy, RMB, Conditional sentence, NDA, IND, Creativity, Small RNA, Marketing, Gastroenterology, Central nervous system, FIC, City, BIC, CMS, NRDL, Injection, Dermatology, CDMO, Commercialization, Tablet, Pharmacy, Methotrexate, Hospital, Acquisition, Gonadotropin-releasing hormone, RCT, VBP, Rheumatoid arthritis, Growth, Varicose veins, Ecosystem, Blue, Government, Ophthalmology

SHENZHEN, CHINA, March 27, 2024 (GLOBE NEWSWIRE) -- On March 27, 2024, China Medical System (“CMS” or the “Company”) released its 2023 annual results.

Key Points: 
  • SHENZHEN, CHINA, March 27, 2024 (GLOBE NEWSWIRE) -- On March 27, 2024, China Medical System (“CMS” or the “Company”) released its 2023 annual results.
  • Based on above, CMS has successfully entered into its “New Period” of innovation and internationalization development.
  • 4 innovative drugs have started large-scale clinical application, unveiling CMS’s first year of commercialization era of innovative drugs.
  • Under its compliant and efficient commercialization system, the Company's innovative products and exclusive drugs will grow steadily.

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023

Retrieved on: 
Thursday, February 15, 2024
Biotechnology, Women, Consumer, Health, Pharmaceutical, Desogestrel, Merck, Ezetimibe, Losartan, Growth, Adalimumab, Atorvastatin, Calcium, Fertility, Etonogestrel, Gonadotropin preparations, Interim, COVID-19, Merck & Co., VBP, Patient, Video game

For the fourth quarter of 2023, total revenue was $1,598 million, an increase of 8% on an as-reported basis as well as excluding impact of foreign currency (ex-FX), compared with the fourth quarter of 2022.

Key Points: 
  • For the fourth quarter of 2023, total revenue was $1,598 million, an increase of 8% on an as-reported basis as well as excluding impact of foreign currency (ex-FX), compared with the fourth quarter of 2022.
  • Women’s Health revenue increased 7% on an as-reported basis, and increased 8% ex-FX in the fourth quarter of 2023 compared with the fourth quarter of 2022 driven primarily by strong growth in the company's fertility products, particularly Follistim AQ® (follitropin beta injection).
  • Revenue of Hadlima™ (adalimumab-bwwd) more than doubled in the fourth quarter of 2023 compared with the fourth quarter of 2022 as a result of continued uptake since its July 2023 launch in the U.S.
  • Established Brands revenue increased 3% as-reported and 3% ex-FX in the fourth quarter of 2023 despite the impacts of Volume Based Procurement (VBP) initiatives and a challenging operating environment in China.

New Report from Health Management Associates Analyzes the Expanding Landscape of Value-Based Entities

Retrieved on: 
Thursday, January 25, 2024
VBP, Enablers (band), Patient, HMA, Research, Policy, Leavitt (surname), Medicare, Partnership, Arnold Ventures LLC, Ecosystem, CMS, Organization, Health Management Associates, Prevalence, Growth, Pharmaceutical industry

LANSING, Mich., Jan. 25, 2024 /PRNewswire/ -- Today, Health Management Associates (HMA) released a new report analyzing the landscape of emerging value-based entities and the implications for accelerating the adoption of accountable care.

Key Points: 
  • Researchers study the growing enabler market, consider benefits and risks, and propose guiding principles and policy recommendations
    LANSING, Mich., Jan. 25, 2024 /PRNewswire/ -- Today, Health Management Associates (HMA) released a new report analyzing the landscape of emerging value-based entities and the implications for accelerating the adoption of accountable care.
  • Despite their prevalence, there has been little formal research into the role, growth, and impact of these entities to date and publicly available information is limited.
  • The report offers a detailed overview of this evolving landscape by introducing a framework for classifying these entities and estimating the size of the market for the first time.
  • Authors examined providers' experiences selecting and collaborating with enablement partners and the role of these entities within Medicare accountable care models and the broader value movement.

Zhang Yu with Tencent Health: AI-Driven Customer Interaction Solution NGES Effectively Supports Pharmaceutical Enterprises' Smart Operations

Retrieved on: 
Wednesday, November 29, 2023
HCP, ASR, Data mining, Empowerment, Feedback, AstraZeneca, Architecture, Health, Teijin, Collection, Voice recognition, CRM, Multimedia, Hospital, Mining, Ecosystem, Artificial intelligence, Marketing, VBP, City, Q&A, Habit, Social media, WeChat, Recognition, Speech, Communication, MCM, Content, AI, Knowledge, Face, Speech recognition, Big data, Optimism, Pharmaceutical industry, Sales, Management, Retail, Online shopping, Tencent

In 2023, Tencent released NGES, a new-gen customer interaction solution catering to Health Care Professionals (HCP), marking another milestone in the digital practice of the pharmaceutical industry.

Key Points: 
  • In 2023, Tencent released NGES, a new-gen customer interaction solution catering to Health Care Professionals (HCP), marking another milestone in the digital practice of the pharmaceutical industry.
  • Zhang Yu, Vice President of Tencent Health and the initiator of the NGES project, has witnessed all these changes.
  • Zhang Yu and his team at Tencent Health have astutely perceived that Tencent has the opportunity to excel in this untapped market space.
  • Zhang Yu stated that Tencent Health has mapped out a well-defined plan for the future development of the NGES customer interaction management platform in three years to come.

Elation Health and AAFP Innovation Lab Showcase Study Results of Value-Based Payment Models for Family Physicians at Annual FMX 2023

Retrieved on: 
Thursday, October 26, 2023
Xchange, Marriott Marquis, Patient, Burnout, Hint, AAFP, Physician, Marriott Marquis Chicago, Health, DPC, Interface (computing), Premier Medical Group, Elation, Psychiatry Innovation Lab, Medicine, American Academy, Family medicine, Chenming Hu, API, Future, American Academy of Family Physicians, X-Change, FMX, SAN, VBP, Nightclub, Medical device, Nursing, Health insurance, Navina Bole

SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Elation Health, the clinical-first technology company powering innovation in primary care, announced today its plans at FMX 2023 in Chicago to discuss the highlights of a second study with the American Academy of Family Physicians (AAFP) Innovation Lab, which identifies key innovations that optimize the family medicine experience. The goal of the 2023 study, conducted with participation from 10 primary care practices of varying sizes, specifically identified barriers to and innovations required for mainstream adoption of value-based payment (VBP) models and its relationship to physician burnout.

Key Points: 
  • SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Elation Health , the clinical-first technology company powering innovation in primary care, announced today its plans at FMX 2023 in Chicago to discuss the highlights of a second study with the American Academy of Family Physicians (AAFP) Innovation Lab, which identifies key innovations that optimize the family medicine experience.
  • The Elation team, including Dr. Sara Pastoor and Nick Dealtry , will be on-site at FMX 2023 and available for attendees interested to learn more about how Elation supports family medicine and primary care physicians delivering the next generation of clinical experiences in value-based payment programs.
  • Event details: Elation Health is speaking and exhibiting at FMX 2023: Ignite - Fired up for Family Medicine's annual gathering.
  • Visit the Freedom Healthworks, Spruce, and Hint booths to collect all four stickers for a chance to win a prize.

Family Physicians with Value-Based Payment Models Relieve Burnout, According to Study from AAFP on Elation Health

Retrieved on: 
Wednesday, October 25, 2023
Burnout, AAFP, Physician, Health, Organization, Research, Harvard Innovation Labs, Interview, Elation, American Academy, Risk, American Academy of Family Physicians, FMX, Movement, Patient, MS, SAN, VBP, Pharmaceutical industry, Nursing, MD

SAN FRANCISCO, Oct. 25, 2023 /PRNewswire/ -- Elation Health, the clinical-first technology company powering innovation in primary care, announced today that the American Academy of Family Physicians (AAFP) Innovation Lab, which identifies key innovations that optimize the family medicine experience, has issued the results of a second collaborative study. The goal of the study this year, conducted by surveying 10 primary care practices of varying sizes, was to identify specific barriers and innovations required for mainstream adoption of value-based payment (VBP) models and their relationship to physician burnout.

Key Points: 
  • "In this second study with Elation Health, we found it critical to further explore the challenges family physicians face as they work to transition to value-based payment models and to understand which innovations help them break through these barriers without putting themselves at risk of burnout."
  • According to another recent AAFP study, more than half of family physicians report being burned out.
  • Key findings from the study illustrate both the promise and the challenges involved with VBP models.
  • Capitation Factors: Practices with capitated models, or risk-adjusted, per-person payment models, experienced less burnout than those with payment models designed around retrospective "bonus" payments.

Clarify Health Recognized in the Gartner® Hype Cycle™ for U.S. Healthcare Payers, 2023 in Two Categories

Retrieved on: 
Tuesday, August 8, 2023
Software, Payments, Health, Artificial Intelligence, Data Management, Health Technology, Technology, Health Insurance, Trigger, Peak, MRF, BCBS, Health care, Blue Cross Blue Shield Association, Health equity, VBP, Intelligence, Multimedia, Gartner hype cycle, Cigna, MD, UnitedHealth Group, Economics, Health insurance, Gartner, Humana

Clarify Health , a leading healthcare analytics and value-based payments platform company, today announced its inclusion in the Gartner Hype Cycle for U.S. Healthcare Payers, 2023 (July 2023) in the Price Transparency Analytics and Next-generation Value-based Payment (NGVBP) categories.

Key Points: 
  • Clarify Health , a leading healthcare analytics and value-based payments platform company, today announced its inclusion in the Gartner Hype Cycle for U.S. Healthcare Payers, 2023 (July 2023) in the Price Transparency Analytics and Next-generation Value-based Payment (NGVBP) categories.
  • View the full release here: https://www.businesswire.com/news/home/20230808477536/en/
    Clarify Health has been included in the Gartner Hype Cycle for U.S. Healthcare Payers, 2023 in both the Price Transparency Analytics and Next-generation Value-based Payment categories.
  • (Graphic: Clarify Health)
    This is the third time this year that Gartner has included Clarify Health in a market analysis.
  • In April, Clarify was named in the Gartner® “Quick Answer: U.S. Healthcare CIOs Use Price Transparency Data to Improve Business Outcomes,” (April 2023).

Dentsply Sirona Reports First Quarter 2023 Results

Retrieved on: 
Wednesday, May 3, 2023
Partnership, Table, Share repurchase, International Dental Show, CAD, VBP, GAAP, Dentsply Sirona, IDS, FDI World Dental Federation, EBITDA, FDI, SureSmile, Growth, EPS, ASR, Video game, Cryptocurrency

First quarter 2023 net sales were $548 million, down (3.0%) versus prior year.

Key Points: 
  • First quarter 2023 net sales were $548 million, down (3.0%) versus prior year.
  • Other 2023 outlook assumptions are included in the first quarter 2023 earnings presentation posted on the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.
  • SureSmile VPro Launch - On April 20, 2023, Dentsply Sirona introduced SureSmile VPro and SureSmile VPro mobile app in the European market as part of its aligner treatment offering.
  • IDS 2023 - From March 14-18, 2023, Dentsply Sirona joined more than 120,000 dental professionals from 162 countries at the International Dental Show (IDS) 2023 in Cologne, Germany.

Net Health's PointRight® Analytics Solution First to Receive Quality Measure Endorsements by National Quality Forum

Retrieved on: 
Thursday, March 30, 2023
Consensus, Partnership, American Health Care Association, Data science, Hospital, Health, VBP, Science, Teijin, CSAC, National Quality Forum, AHCA, Patient, NQF, CDP, SVP, Incubation, Nursing, Medical device, Management, Research

PITTSBURGH, March 30, 2023 /PRNewswire/ -- Net Health, a leading provider of cloud-based software for specialty medical providers, today announced its PointRight® solution received two endorsements by the National Quality Forum (NQF). The endorsements include the PointRight® Pro 30® all-cause, risk adjusted rehospitalization (NQF #2375) and the PointRight® Pro Long Stay™ all-cause adjusted long-stay resident hospitalization (NQF #2827) measures.

Key Points: 
  • PITTSBURGH, March 30, 2023 /PRNewswire/ -- Net Health , a leading provider of cloud-based software for specialty medical providers, today announced its PointRight® solution received two endorsements by the National Quality Forum (NQF).
  • There are currently no other long-term and post-acute care (LTPAC) EHR or analytics vendors who have developed NQF-endorsed quality measures.
  • "Earning these two endorsements further demonstrates Net Health's commitment to providing accurate performance analytics through its PointRight solutions."
  • "These endorsements validate Net Health's goal of delivering quality predictive analytics, enabling providers and payers to align on value-based care initiatives."

ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Wednesday, March 1, 2023
Rationalization, EPS, EBITDA, Brainlab, Policy, Spine, ERP, VBP, Partnership, Scoliosis, Omicron, COVID-19, Adjustment, Reinsurance, Cryptocurrency, Natural gas, Anthem, Highmark

Both segments were unfavorably impacted by one less selling day in the fourth quarter of 2022.

Key Points: 
  • Both segments were unfavorably impacted by one less selling day in the fourth quarter of 2022.
  • Adjusted net income[1] for the fourth quarter of 2022 was $4.3 million, an increase of $13.6 million versus the same prior year period.
  • Basic and diluted EPS were ($1.16) and adjusted diluted EPS[1] was $0.16 for the fourth quarter of 2022.
  • Adjusted EBITDA[1] for the fourth quarter of 2022 was $28.1 million, or 12.3%, a 70 basis point increase from the fourth quarter of 2021.